Adaptive Biotechnologies ADPT
NASDAQ ADPT
$28.60 +0.93 (+3.36%)
As of: Sep 17, 2026 · 3:59 PM EDT

Adaptive Biotechnologies (ADPT) Operating Margin Growth (3y) (2021 - 2026)

Analysis

Adaptive Biotechnologies (ADPT) Operating Margin Growth (3y) (2021 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin Growth (3y) (Qtr)
1 Natera 49.39 Bn 48.29 Bn 486.15 Mn 3,294.00
2 Quest Diagnostics 27.49 Bn 26.86 Bn 1.03 Bn 20.00
3 Labcorp Holdings 26.51 Bn 26.37 Bn 1.11 Bn 333.00
4 Guardant Health 23.17 Bn 22.12 Bn 219.03 Mn 4,867.00
5 Tempus AI 12.59 Bn 11.77 Bn 274.25 Mn 1,424.00
6 Caris Life Sciences 8.01 Bn 7.22 Bn 182.38 Mn -
7 Sotera Health 5.53 Bn 5.17 Bn 177.96 Mn 941.00
8 BillionToOne 4.80 Bn 4.25 Bn 77.11 Mn -
9 Adaptive Biotechnologies 4.40 Bn 4.05 Bn 51.39 Mn 7,570.00
10 iRhythm Holdings 3.68 Bn 3.08 Bn 163.21 Mn 1,407.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 7,570.00
Mar 31, 2026 12,482.00
Dec 31, 2025 5,317.00
Sep 30, 2025 10,593.00
Jun 30, 2025 7,773.00
Mar 31, 2025 10,685.00
Dec 31, 2024 9,110.00
Sep 30, 2024 7,244.00
Jun 30, 2024 1,969.00
Mar 31, 2024 -907.00
Dec 31, 2023 -866.00
Sep 30, 2023 649.00
Jun 30, 2023 7,812.00
Mar 31, 2023 1,365.00
Dec 31, 2022 2,892.00
Sep 30, 2022 -2,570.00
Jun 30, 2022 -4,750.00
Mar 31, 2022 -504.00
Dec 31, 2021 -8,012.00
Sep 30, 2021 -8,942.00